Have you been diagnosed with cancer?

With many cancers, genetic testing is recommended at the time of diagnosis. Genetic testing reveals important features, including mutations and other specific markers for treatment response. Some of these features can be targeted by therapies. The results from your genetic testing can help your provider personalize treatment plans to target specific features of your cancer.

Our commitment
BostonGene’s mission is to power healthcare’s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics.
What sets BostonGene apart?
Every cancer and every patient is unique. Our approach uncovers unique features of each tumor enabling doctors to design the best treatment for your cancer. BostonGene is the first and only company to use a comprehensive artificial intelligence-based platform to holistically analyze each tumor, the area around the tumor, and immunity to uncover treatable targets unique to you to personalize your therapy.
Meet our patients

Read our case studies to learn how BostonGene Tumor Portrait™ Tests have enabled personalized treatment options based on molecular and immune profiles.

By sharing these inspirational stories, we hope to encourage all patients to undergo genetic testing to optimize your treatment.

The Science
Our approach
Using artificial intelligence and next-generation DNA and RNA sequencing, the BostonGene Tumor Portrait™ Test provides the most accurate and comprehensive view of your tumor’s biology and its interaction with your immune system.
Tumor Portrait™ Test
Your BostonGene Tumor Portrait™ Test report provides important information including tumor composition, what genes drive your tumor’s growth, how your immune system is responding to the tumor, treatment recommendations, and potentially beneficial clinical trials.
Liquid biopsy
BostonGene’s Liquid Biopsy test covers all genes recommended by the National Comprehensive Cancer Network, including those most relevant to patient care providing physicians with a complete genomic profile from a single blood sample. Our clinical test detects all types of biomarkers including single nucleotide polymorphisms (SNPs) / indels (somatic), copy number alterations (CNAs), rearrangements, microsatellite instability (MSI) status.
Integrated genomic registry
At BostonGene, we are committed to advancing the landscape of cancer research. We welcome all eligible patients to participate in our BostonGene-Integrated Genomic Registry (BIGR) study to improve outcomes for future cancer patients. Contact us to learn more.
Financial assistance
BostonGene is committed to working with your financial situation and finding a way to make our tests affordable. We have designed a Financial Assistance program that could offer a better understanding of what your maximum out-of-pocket cost would be and allow you some financial flexibility. We encourage you to apply for financial assistance prior to the test administration, but if you don’t, the program is available to you at any point of the journey. The program covers longitudinal testing for up to 18 months.
Patient’s FAQs
Why did my physician order the test?
What will be included in the report?
Who will receive the test results?
Contact us